Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Orthopedics: Zimmer disappoints The Street with mixed quarter
Zimmer gets conservative on guidance as sales at the medical device company remain relatively flat; The Street pushes shares lower through midday trading.
2. Covidien sees growth in U.S., troubles in Europe
Medical device maker Covidien reports its 3rd quarter earnings, touting strong growth in U.S. sales but no growth internationally.
1. CRM slump continues as BSX swings to a loss in Q2, lowers guidance for 2012
Boston Scientific takes a non-cash $3.4 billion impairment of goodwill charge to its bottom line over weakening economic conditions, sending the medical device company to a loss for the quarter; DES, CRM and ICD sales slump badly in the quarter as 2012 outlook lowered.